ESC-RCC carries mutations in TSC1 or TSC2, with recurrent mutually exclusive somatic bi-allelic loss of TSC1/2, resulting in hyperactive mTORC1 signaling. The gene discussed is TSC1; the disease is renal cell carcinoma.